To test this hypothesis, we performed a case–control study to evaluate the effects of HBV genotype, mutations in the EnhII/BCP/PC region, PTPN12 eQTLs SNPs, and their interactions on HCC risk. Here, PTPN12 is linked to hepatocellular carcinoma.